Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) Return on Equity (2016 - 2025)

Historic Return on Equity for BioCorRx (BICX) over the last 16 years, with Q3 2025 value amounting to 0.32%.

  • BioCorRx's Return on Equity fell 1100.0% to 0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.32%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 4.34% for FY2024, which is 86500.0% up from last year.
  • According to the latest figures from Q3 2025, BioCorRx's Return on Equity is 0.32%, which was down 1100.0% from 0.4% recorded in Q2 2025.
  • BioCorRx's Return on Equity's 5-year high stood at 8.73% during Q1 2024, with a 5-year trough of 10.9% in Q4 2023.
  • For the 5-year period, BioCorRx's Return on Equity averaged around 0.43%, with its median value being 0.52% (2023).
  • Per our database at Business Quant, BioCorRx's Return on Equity plummeted by -114600bps in 2023 and then soared by 113200bps in 2024.
  • BioCorRx's Return on Equity (Quarter) stood at 0.83% in 2021, then crashed by -31bps to 0.57% in 2022, then crashed by -2017bps to 10.9% in 2023, then soared by 104bps to 0.43% in 2024, then fell by -25bps to 0.32% in 2025.
  • Its last three reported values are 0.32% in Q3 2025, 0.4% for Q2 2025, and 0.4% during Q1 2025.